On May 13th, Global News Health Matters segment featured Inagene and Pharmacogenetic testing (PGx), helping to bring awareness to how this new science is revolutionizing the way drugs are prescribed, and empowering Canadians living with mental health conditions to move beyond the antiquated “trial and error” method of finding the right treatment and start feeling better, sooner.
Inagene and dnaPower Launch the fourth Episode of The Healthy Helix; a series supporting education, innovation and information across the healthcare landscape.
Inagene Diagnostics, in partnership with dnaPower, explores health through the lens of genetics, personalized medicine and prevention to help individuals make the best decisions to live their healthiest lives in the context of COVID-19.
Inagene Diagnostics in partnership with dnaPower, take a dive deep to inform consumers how their test results can be transformative in achieving their best health
Inagene Diagnostics Inc. is proud to attend the Canadian Pain Society webinar co-presented by our Chief Science Advisor, Katherine Siminovitch on November 10th
Nancy White, CEO of Inagene Diagnostics participated in a Panel Discussion at the 20th Annual Healthcare Summit (October 26-27, 2020), which focused on how COVID-19 is changing the private and public healthcare sector, both in terms of impacts as well as opportunities.
Inagene Diagnostics Inc. had the pleasure of attending and proudly sponsoring the Pain Society of Alberta’s Virtual Pain Conference – a history making event as, with over 4200 Registrants, it was the largest pain conference in Canada’s history!